Search

There are many ongoing clinical and laboratory studies around the world, exploring innovative approaches to treating inherited sight loss.

• News

SpliceBio has begun the dose-expansion portion of their phase 1/2 clinical trial of SB-007, a dual adeno-associated viral vector gene therapy for Stargardt disease.

• News
• Stargardt disease

Mirugen – Unlocking the Power of Retina Regeneration

• News
• Retinitis pigmentosa
• Stargardt disease

Sepul Bio begins clinical trial of ultevursen for USH2A-associated RP

• News
• Retinitis pigmentosa

The latest research news from Retina UK.

• News
• Stargardt disease

Please read our conditions of use carefully as by using the website you will be assumed to have agreed to be bound by them.

Researchers from the University Hospital Tübingen in Germany recently announced that there were no signs of visual gains in an early-phase clinical trial of a PDE6A gene therapy for Retinitis Pigmentosa (RP).

• News
• Retinitis pigmentosa

Several groups around the world are investigating the use of retinal transplantation in the treatment of inherited retinal diseases.

Our monthly e-Newsletter featuring the latest updates from Retina UK. Subscribe now to receive these updates directly to your email.

• e-Newsletter
• Audio
• Written

The cover of this edition celebrates the success of our amazing London Marathon team. Together they have raised more than £43,000.

• Look Forward
• Audio
• Written